These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36503376)

  • 41. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of disease activity in Systemic Lupus Erythematosus: Lights and shadows.
    Ceccarelli F; Perricone C; Massaro L; Cipriano E; Alessandri C; Spinelli FR; Valesini G; Conti F
    Autoimmun Rev; 2015 Jul; 14(7):601-8. PubMed ID: 25742757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus.
    Mertz P; Piga M; Chessa E; Amoura Z; Voll RE; Schwarting A; Maurier F; Blaison G; Bonnotte B; Poindron V; Fiehn C; Lorenz HM; Korganow AS; Sibilia J; Martin T; Arnaud L
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 36123013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Childhood Systemic Lupus Erythematosus: Presentation, management and long-term outcomes in an Australian cohort.
    Cann MP; Sage AM; McKinnon E; Lee SJ; Tunbridge D; Larkins NG; Murray KJ
    Lupus; 2022 Feb; 31(2):246-255. PubMed ID: 35037500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes.
    Rogers JL; Eudy AM; Pisetsky D; Criscione-Schreiber LG; Sun K; Doss J; Clowse MEB
    Arthritis Care Res (Hoboken); 2021 Mar; 73(3):386-393. PubMed ID: 31909888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms.
    Askanase AD; Castrejón I; Pincus T
    J Rheumatol; 2011 Jul; 38(7):1309-16. PubMed ID: 21459938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in quality of life in relation to disease activity in systemic lupus erythematosus: post-hoc analysis of the BLISS-52 Trial.
    Jolly M; Annapureddy N; Arnaud L; Devilliers H
    Lupus; 2019 Dec; 28(14):1628-1639. PubMed ID: 31674267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.
    Touma Z; Gladman DD; Ibañez D; Taghavi-Zadeh S; Urowitz MB
    J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB; Bae SC
    Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison between disease onset patterns of Egyptian juvenile and adult systemic lupus erythematosus (single centre experience).
    Abdel-Nabi HH; Abdel-Noor RA
    Lupus; 2018 May; 27(6):1039-1044. PubMed ID: 29460702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
    Brunner HI; Feldman BM; Bombardier C; Silverman ED
    Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disease activity and damage in hospitalized lupus patients: a Sabah perspective.
    Selvananda S; Chong YY; Thundyil RJ
    Lupus; 2020 Mar; 29(3):344-350. PubMed ID: 32046576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort.
    Medhat BM; Behiry ME; Sobhy N; Farag Y; Marzouk H; Mostafa N; Khalifa I; Elkhalifa M; Eissa BM; Hassan EHE
    Clin Rheumatol; 2020 Feb; 39(2):435-442. PubMed ID: 31758421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of Serum β2-microglobulin in Egyptian Patients with Systemic Lupus Erythematosus.
    Abd-Elbaky NM; Albeltagy ES; Hammour AE; Ibrahim AS
    Egypt J Immunol; 2019 Jul; 26(2):143-153. PubMed ID: 31926503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Translation, cultural adaptation and validation of the Systemic Lupus Erythematosus Activity Questionnaire (SLAQ) in a cohort of Italian systemic lupus erythematosus patients.
    Tani C; Vagelli R; Stagnaro C; Carli L; Lorenzoni V; Drago F; Doherty W; McSorley MR; Marconcini L; Della Rossa A; Turchetti G; Mosca M
    Lupus; 2018 Sep; 27(10):1735-1741. PubMed ID: 30045666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-Smith antibody is associated with disease activity in patients with new-onset systemic lupus erythematosus.
    Ahn SS; Jung SM; Yoo J; Lee SW; Song JJ; Park YB
    Rheumatol Int; 2019 Nov; 39(11):1937-1944. PubMed ID: 31552434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
    Lewandowski LB; Schanberg LE; Thielman N; Phuti A; Kalla AA; Okpechi I; Nourse P; Gajjar P; Faller G; Ambaram P; Reuter H; Spittal G; Scott C
    Lupus; 2017 Feb; 26(2):186-194. PubMed ID: 27488473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chinese SLE Treatment and Research group (CSTAR) registry: V. gender impact on Chinese patients with systemic lupus erythematosus.
    Zhang S; Su J; Li X; Zhang X; Liu S; Wu L; Ma L; Bi L; Zuo X; Sun L; Huang C; Zhao J; Li M; Zeng X;
    Lupus; 2015 Oct; 24(12):1267-75. PubMed ID: 25972364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biomarkers for systemic lupus erythematosus - a focus on organ damage.
    Ding H; Shen Y; Hong SM; Xiang C; Shen N
    Expert Rev Clin Immunol; 2024; 20(1):39-58. PubMed ID: 37712757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
    Appenzeller S; Pereira DA; Costallat LT
    Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.